1466 — Acelon Chemicals & Fiber Balance Sheet
0.000.00%
- TWD1.72bn
- TWD2.98bn
- TWD2.94bn
- 26
- 31
- 58
- 30
Annual balance sheet for Acelon Chemicals & Fiber, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 391 | 421 | 298 | 263 | 279 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 429 | 562 | 375 | 404 | 473 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,355 | 1,768 | 1,517 | 1,447 | 1,455 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,803 | 1,775 | 1,829 | 1,848 | 1,828 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 3,420 | 3,685 | 3,487 | 3,441 | 3,453 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 620 | 1,152 | 842 | 815 | 777 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,844 | 1,929 | 1,891 | 1,997 | 1,990 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 1,576 | 1,756 | 1,596 | 1,444 | 1,463 |
Total Liabilities & Shareholders' Equity | 3,420 | 3,685 | 3,487 | 3,441 | 3,453 |
Total Common Shares Outstanding |